High Purity Lipopeptides
First Claim
1. A composition comprising(a) essentially pure daptomycin,(b) daptomycin that is substantially free of anhydro-daptomycin and substantially free of β
- -isomer of daptomycin,(c) daptomycin that is essentially free of anhydro-daptomycin and substantially free of β
-isomer of daptomycin,(d) daptomycin that is free of anhydro-daptomycin and substantially free of β
-isomer of daptomycin,(e) daptomycin that is substantially free of each of impurities 1 to 14 defined by peaks 1-14 shown in FIG. 12,(f) daptomycin that is essentially free of each of impurities 1 to 14 defined by peaks 1-14 shown in FIG. 12, or(g) substantially pure daptomycin.
5 Assignments
0 Petitions
Accused Products
Abstract
The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential steps of anion exchange chromatography, hydrophobic interaction chromatography and anion exchange chromatography. The invention also discloses a method of purifying daptomycin by modified buffer enhanced anion exchange chromatography. The invention also discloses an improved method for producing daptomycin by fermentation of Streptomyces roseosporus. The invention also discloses high pressure liquid chromatography methods for analysis of daptomycin purity. The invention also discloses lipopeptide micelles and methods of making the micelles. The invention also discloses methods of using lipopeptide micelles for purifying lipopeptide antibiotics, such as daptomycin. The invention also discloses using lipopeptide micelles therapeutically.
12 Citations
53 Claims
-
1. A composition comprising
(a) essentially pure daptomycin, (b) daptomycin that is substantially free of anhydro-daptomycin and substantially free of β - -isomer of daptomycin,
(c) daptomycin that is essentially free of anhydro-daptomycin and substantially free of β
-isomer of daptomycin,(d) daptomycin that is free of anhydro-daptomycin and substantially free of β
-isomer of daptomycin,(e) daptomycin that is substantially free of each of impurities 1 to 14 defined by peaks 1-14 shown in FIG. 12 ,(f) daptomycin that is essentially free of each of impurities 1 to 14 defined by peaks 1-14 shown in FIG. 12 , or(g) substantially pure daptomycin. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)
- -isomer of daptomycin,
Specification